David Slosky

The 3 million prostate cancer survivors in the United States are likely to die from something other than cancer, thanks to early detection, effective treatment and the disease’s slow progression. Read More

Vanderbilt is embarking on a multi-disciplinary approach to understand how promising cancer treatments, specifically certain kinase inhibitors, affect the heart and kidneys. Read More

The Vanderbilt Cardio-Oncology program has fostered a collaborative relationship combining the expertise of cardiologists and oncologists to understand effects of cancer therapy on the heart. Read More

The Vanderbilt Cardio-Oncology program has fostered a special collaborative relationship combining the expertise of cardiologists and oncologists to understand the effects of cancer therapy on the heart. This type of collaboration is now helping to define the cardiovascular health of more than 14 million cancer survivors in the United States. Read More

Vanderbilt Heart and Vascular Institute (VHVI) is relocating its cardiac practice in Williamson County and announcing the addition of five cardiologists. Formerly located at 2105 Edward Curd Lane in Franklin, Tenn., the practice will relocate to 4323 Carothers Pkwy., Suite 405, within the Williamson Tower, the medical office building attached… Read More

Vanderbilt Heart and Vascular Institute (VHVI) is relocating its cardiac practice in Williamson County and announcing the addition of five cardiologists. Formerly located at 2105 Edward Curd Lane in Franklin, Tenn., the practice will relocate to 4323 Carothers Pkwy., Suite 405, within Williamson Tower, the medical office… Read More